CN103705392B - 一种小核酸美白祛斑霜及其制备方法 - Google Patents
一种小核酸美白祛斑霜及其制备方法 Download PDFInfo
- Publication number
- CN103705392B CN103705392B CN201210369781.2A CN201210369781A CN103705392B CN 103705392 B CN103705392 B CN 103705392B CN 201210369781 A CN201210369781 A CN 201210369781A CN 103705392 B CN103705392 B CN 103705392B
- Authority
- CN
- China
- Prior art keywords
- small nucleic
- nucleic acids
- whitening
- transdermal
- active component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 47
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 47
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 47
- 230000002087 whitening effect Effects 0.000 title claims abstract description 40
- 239000006071 cream Substances 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims description 15
- 208000003351 Melanosis Diseases 0.000 title abstract description 12
- 239000002537 cosmetic Substances 0.000 claims abstract description 10
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 36
- 239000004475 Arginine Substances 0.000 claims description 35
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 35
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 30
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 30
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 22
- 239000002253 acid Substances 0.000 claims description 21
- 239000004006 olive oil Substances 0.000 claims description 20
- 235000008390 olive oil Nutrition 0.000 claims description 20
- -1 polydimethylsiloxane Polymers 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 12
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 10
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims description 10
- PKJBRKTYYNRVSN-UHFFFAOYSA-N 10-(aminomethyl)-9,10-dihydroanthracene-1,2-diol Chemical compound OC1=CC=C2C(CN)C3=CC=CC=C3CC2=C1O PKJBRKTYYNRVSN-UHFFFAOYSA-N 0.000 claims description 10
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 10
- 244000173166 Pyrus ussuriensis Species 0.000 claims description 10
- 235000011572 Pyrus ussuriensis Nutrition 0.000 claims description 10
- 235000021355 Stearic acid Nutrition 0.000 claims description 10
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 10
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 10
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 10
- 229940008099 dimethicone Drugs 0.000 claims description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 10
- 229960005150 glycerol Drugs 0.000 claims description 10
- 229920002674 hyaluronan Polymers 0.000 claims description 10
- 229960003160 hyaluronic acid Drugs 0.000 claims description 10
- 235000019136 lipoic acid Nutrition 0.000 claims description 10
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 10
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 10
- 239000008117 stearic acid Substances 0.000 claims description 10
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 claims description 10
- 229960002663 thioctic acid Drugs 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 239000008346 aqueous phase Substances 0.000 claims description 7
- 239000002105 nanoparticle Substances 0.000 claims description 7
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 239000012071 phase Substances 0.000 claims description 6
- 238000007599 discharging Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000006386 neutralization reaction Methods 0.000 claims description 3
- 241001331845 Equus asinus x caballus Species 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 229920001187 thermosetting polymer Polymers 0.000 claims 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 6
- 230000003020 moisturizing effect Effects 0.000 abstract description 2
- 108010051109 Cell-Penetrating Peptides Proteins 0.000 abstract 1
- 102000020313 Cell-Penetrating Peptides Human genes 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 17
- 238000000034 method Methods 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 7
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 6
- 206010008570 Chloasma Diseases 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 210000004927 skin cell Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000037259 Amyloid Plaque Diseases 0.000 description 3
- 108020004459 Small interfering RNA Proteins 0.000 description 3
- 206010042496 Sunburn Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- XKZQKPRCPNGNFR-UHFFFAOYSA-N 2-(3-hydroxyphenyl)phenol Chemical compound OC1=CC=CC(C=2C(=CC=CC=2)O)=C1 XKZQKPRCPNGNFR-UHFFFAOYSA-N 0.000 description 2
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 2
- 101000773083 Homo sapiens 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 108010011110 polyarginine Proteins 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XUNKPNYCNUKOAU-VXJRNSOOSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]a Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O XUNKPNYCNUKOAU-VXJRNSOOSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- 206010001557 Albinism Diseases 0.000 description 1
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- 101100315627 Caenorhabditis elegans tyr-3 gene Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101000796203 Homo sapiens L-dopachrome tautomerase Proteins 0.000 description 1
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 1
- 102000013760 Microphthalmia-Associated Transcription Factor Human genes 0.000 description 1
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 101150087532 mitF gene Proteins 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000000158 ommatidium Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 101150042775 tyr1 gene Proteins 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
序列表 | 小RNA名 | 序列方向5’-3’ |
1 | TYR1 | 5’-GAGGAACUGUUAUUUGUAUGUGA-3’ |
2 | TYR2 | 5’-ACCUCUUUGUCUGGAUGCAUUAUUA-3’ |
3 | TYR3 | CAACAGCCAUCAGUCUUUAUGCAAU |
4 | TYR4 | GCCUACCUCACUUUAGCAA |
5 | TYR5 | GCAGCAUGCACAAUGCCUU |
6 | TYR6 | GGGCCAAAAAGCCUGACCUCACUCU |
7 | MITF1 | GCUCAGAAUACAGGAACUU |
8 | MITF2 | GCUCGAGCUCAUGGACUUU |
9 | MITF3 | GCAGUACCUUUCUACCAUAG |
10 | MITF4 | CGCUGGAACAAGGGAACCAUCUUAA |
11 | MITF5 | UGCAUUCGCACAAACUGCUUCCUUU |
12 | MITF6 | UUGCAUAGGAUUCACAAAAGUGGAU |
13 | MITF7 | GCUUGGUACUGUAAUGUUAAUAA |
14 | TYRP1 | ACGCCACAAUUUGAGAACAUUUCCA |
15 | TYRP2 | GAAGCAACUUUGAUUCCACUCUAAU |
16 | TYRP3 | GCCCUACUCUCUUAUGCAUUAGU |
17 | TYRP4 | AGCAUUAUCUUAUCAUUUAUCA |
18 | TYRP5 | GGCAUAUGGAGAACAUGUUUUA |
19 | TYRP6 | AGGUGGUCAUAAGUGAAUAUUU |
20 | TYRP7 | GUUCCGAGGUUGUUGUUCAUU |
序列表 | 多聚肽名` | 序列方向N端-C端 |
21 | R6a(精氨酸6聚体) | RRRRRR |
22 | R6b(精氨酸6聚体) | RRRRRSR |
23 | R6c(精氨酸6聚体) | RRRRRRW |
24 | R7a(精氨酸7聚体) | RRRRRRR |
25 | R7b(精氨酸7聚体) | RRRRRRSR |
26 | R7c(精氨酸7聚体) | RRRRRRRW |
27 | R8a(精氨酸8聚体) | RRRRRRRR |
28 | R8b(精氨酸8聚体) | RRRRRRRSR |
29 | R8c(精氨酸8聚体) | RRRRRRRRW |
30 | R9a(精氨酸9聚体) | RRRRRRRRR |
31 | R9b(精氨酸9聚体) | RRRRRRRRSR |
32 | R9c(精氨酸9聚体) | RRRRRRRRRW |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210369781.2A CN103705392B (zh) | 2012-09-29 | 2012-09-29 | 一种小核酸美白祛斑霜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210369781.2A CN103705392B (zh) | 2012-09-29 | 2012-09-29 | 一种小核酸美白祛斑霜及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103705392A CN103705392A (zh) | 2014-04-09 |
CN103705392B true CN103705392B (zh) | 2015-02-18 |
Family
ID=50398992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210369781.2A Active CN103705392B (zh) | 2012-09-29 | 2012-09-29 | 一种小核酸美白祛斑霜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103705392B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160001419A (ko) * | 2014-06-27 | 2016-01-06 | 포항공과대학교 산학협력단 | 양이온성 분자 수송체 및 음이온성 생리활성 물질을 포함하는 피부 투과용 조성물 |
CN106333870B (zh) * | 2015-07-08 | 2019-06-14 | 上海铂源健康科技有限公司 | 一种去角质补水面膜及其制备方法 |
FR3043695B1 (fr) * | 2015-11-17 | 2019-10-25 | ISP Investments LLC. | Procede d'obtention d'un extrait aqueux enrichi en petits arn a partir d'une matiere vegetal et extraits issus du procede |
CN106983713B (zh) * | 2017-03-31 | 2020-06-26 | 杭州哈佛赛尔干细胞技术有限公司 | 一种干细胞护肤组合物及其制备方法和使用方法 |
FR3066113B1 (fr) * | 2017-05-12 | 2020-06-05 | ISP Investments LLC. | Procede d’obtention d’un extrait aqueux d’anethum graveolens enrichi en petits arn |
CN110090165B (zh) * | 2019-05-08 | 2021-08-24 | 浙江大学 | 一种小核酸纳米美白霜及制备方法与应用 |
CN111888274A (zh) * | 2020-07-17 | 2020-11-06 | 重庆珂蓝健康管理集团有限公司 | 一种快速4小时分离色斑的方法 |
CN111956519A (zh) * | 2020-07-17 | 2020-11-20 | 重庆珂蓝健康管理集团有限公司 | 一种小核酸快速安全祛斑护肤品 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101601635A (zh) * | 2008-06-13 | 2009-12-16 | 殷勤伟 | 小rna/dna美白产品的配方和制造方法 |
-
2012
- 2012-09-29 CN CN201210369781.2A patent/CN103705392B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101601635A (zh) * | 2008-06-13 | 2009-12-16 | 殷勤伟 | 小rna/dna美白产品的配方和制造方法 |
Non-Patent Citations (1)
Title |
---|
细胞穿透肽及其结构改造在siRNA传递中的应用;张洪杰等;《生物化学与生物物理进展》;20120531;第29卷(第5期);402-409页,第1、4节 * |
Also Published As
Publication number | Publication date |
---|---|
CN103705392A (zh) | 2014-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103705392B (zh) | 一种小核酸美白祛斑霜及其制备方法 | |
JP7450979B2 (ja) | 二剤型エッセンス及びその製造方法 | |
CN102030615B (zh) | 4-己基间苯二酚的高透明度水性浓缩物 | |
CN102366384B (zh) | 一种焕颜修容霜组合物及其制备方法 | |
CN101530377B (zh) | 皮肤外用祛斑功效纳米乳组合产品及其制备方法 | |
JP2000229828A (ja) | 美白用皮膚外用剤 | |
KR101353628B1 (ko) | 기초화장품용 배합제 및 기초화장품 | |
CN108938513A (zh) | 一种量子清肤祛痘美颜霜及其制备方法 | |
KR101259452B1 (ko) | 나노에멀젼 유화제 및 이를 함유하는 화장료 조성물 | |
JP2008143784A (ja) | 細胞増殖促進剤 | |
CN112245571A (zh) | 一种用于乌发的脂质体制剂及其制备方法 | |
JP5959995B2 (ja) | 皮膚のしわ形成防止・改善剤 | |
JP3987793B2 (ja) | 皮膚外用剤 | |
CN1408338A (zh) | 脂质体美白化妆品及其制造方法 | |
KR102058445B1 (ko) | 복숭아꽃 추출물이 함유된 나노리포좀을 이용한 화장료 조성물 | |
KR20100104144A (ko) | 마유 및 말태반 추출물이 내포된 수용성 나노리포좀을 포함하는 피부 미백용 조성물 | |
JP2001114636A (ja) | ヒアルロン酸産生及びカタラーゼ産生促進剤、線維芽細胞賦活剤、並びに皮膚外用剤 | |
CN103860444B (zh) | 含有抑制黑色素生成的siRNA细胞培养物美白精华液 | |
CN115282087A (zh) | 一种可渗透至真皮层的纳米黄金油肽及其制备方法和应用 | |
CN109771320A (zh) | 燕窝肽和植物精油复配的护肤品及其制备方法 | |
CN108543079A (zh) | 一种虾青素-胶原蛋白耦合物及其制备方法和应用 | |
JP2009242310A (ja) | インボルクリン産生促進剤、トランスグルタミナーゼ−1産生促進剤、e−カドヘリン産生促進剤、及び毛穴目立ち軽減用皮膚外用剤 | |
KR101957411B1 (ko) | 생약 추출물 함포 펙틴 마이크로캡슐을 포함하는 피부 개선용 화장료 조성물 | |
JP3946418B2 (ja) | メラニン生成抑制剤 | |
JP2008088074A (ja) | 皮膚の老化機構に作用する剤、抗老化用皮膚外用剤、及び抗老化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DD01 | Delivery of document by public notice |
Addressee: Huang Bing Document name: Notification to Make Rectification Addressee: Huang Bing Document name: Notice of not requiring priority (domestic) |
|
DD01 | Delivery of document by public notice |
Addressee: Yin Qinwei Document name: Notification that Application Deemed to be Withdrawn |
|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: YIN QINWEI Effective date: 20150630 Owner name: JIANGSU GENECON BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: HUANG BING Effective date: 20150630 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150630 Address after: 226000 Jiangsu city of Nantong province Nantong economic and Technological Development Zone No. 76 Chang Xing Lu Patentee after: Jiangsu GeneCon Biological Technology Co., Ltd. Address before: 100101 Beijing city Chaoyang District Ding Road century Baoding apartment 801 Patentee before: Huang Bing Patentee before: Yin Qinwei |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160630 Address after: 201203 Room 518, No. 212 blue wave road, Zhangjiang hi tech park, Shanghai Patentee after: Shanghai platinum Health Technology Co., Ltd. Address before: 226000 Jiangsu city of Nantong province Nantong economic and Technological Development Zone No. 76 Chang Xing Lu Patentee before: Jiangsu GeneCon Biological Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190802 Address after: 226016 Jiangsu city of Nantong Province Economic and Technological Development Zone No. 76 Chang Xing Lu Patentee after: Jiangsu GeneCon Biological Technology Co., Ltd. Address before: 201203 Room 518, No. 212 blue wave road, Zhangjiang hi tech park, Shanghai Patentee before: Shanghai platinum Health Technology Co., Ltd. |